Inspiration meets innovation at Brandweek, the ultimate marketing experience. Join industry luminaries, rising talent and strategic experts in Phoenix, Arizona this September 23–26 to assess challenges, develop solutions and create new pathways for growth. Register early to save.
McCann-Erickson has won a review for creative duties on the estimated $50 million account of Novartis’ Lotrel hypertension medicine, sources said. The IPG shop bested sibling Deutsch and WPP’s Ogilvy & Mather, both in New York, and The Quantum Group in Parsippany, N.J. Novartis has advertised the drug to medical professionals but now wants to target consumers, sources said.
Agency executives referred calls to client officials, who could not be reached.
WORK SMARTER - LEARN, GROW AND BE INSPIRED.
Subscribe today!
To Read the Full Story Become an Adweek+ Subscriber
Already a member? Sign in